BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1944409)

  • 1. Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy.
    Bromberg MB
    Muscle Nerve; 1991 Oct; 14(10):968-76. PubMed ID: 1944409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and specificity of electrodiagnostic criteria for CIDP using ROC curves: comparison to patients with diabetic and MGUS associated neuropathies.
    Wilson J; Chawla J; Fisher M
    J Neurol Sci; 2005 Apr; 231(1-2):19-28. PubMed ID: 15792816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrodiagnostic criteria in CIDP: comparison with diabetic neuropathy.
    Wilson JR; Park Y; Fisher MA
    Electromyogr Clin Neurophysiol; 2000; 40(3):181-5. PubMed ID: 10812541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relative diagnostic sensitivity of different F-wave parameters in various polyneuropathies.
    Fraser JL; Olney RK
    Muscle Nerve; 1992 Aug; 15(8):912-8. PubMed ID: 1495506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.
    De Sousa EA; Chin RL; Sander HW; Latov N; Brannagan TH
    J Clin Neuromuscul Dis; 2009 Jun; 10(4):163-9. PubMed ID: 19494726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy.
    Van den Bergh PY; PiƩret F
    Muscle Nerve; 2004 Apr; 29(4):565-74. PubMed ID: 15052622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of electrodiagnostic criteria for demyelination in patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
    Molenaar DS; Vermeulen M; de Haan RJ
    J Neurol; 2002 Apr; 249(4):400-3. PubMed ID: 11967643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Narasimhan M
    Clin Neurophysiol; 2007 Sep; 118(9):1999-2004. PubMed ID: 17644033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy.
    Van Asseldonk JT; Van den Berg LH; Kalmijn S; Wokke JH; Franssen H
    Brain; 2005 Apr; 128(Pt 4):880-91. PubMed ID: 15689367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.
    Magda P; Latov N; Brannagan TH; Weimer LH; Chin RL; Sander HW
    Arch Neurol; 2003 Dec; 60(12):1755-9. PubMed ID: 14676052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segmental evaluation of the peripheral nerve using tibial nerve SEPs for the diagnosis of CIDP.
    Tsukamoto H; Sonoo M; Shimizu T
    Clin Neurophysiol; 2010 Jan; 121(1):77-84. PubMed ID: 19850515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conduction block in diabetic neuropathy.
    Abu-Shakra SR; Cornblath DR; Avila OL; Chaudhry V; Freimer M; Glass JD; Reim JW; Ronnett GV
    Muscle Nerve; 1991 Sep; 14(9):858-62. PubMed ID: 1922181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incidence of diabetic neuropathy which fulfills electrophysiologic criteria of CIDP].
    Miyasaki H; Hasegawa O; Mori I; Matsumoto S; Arita T
    No To Shinkei; 1999 May; 51(5):415-8. PubMed ID: 10396747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute inflammatory demyelinating polyneuropathy: contribution of a dispersed distal compound muscle action potential to electrodiagnosis.
    Cleland JC; Malik K; Thaisetthawatkul P; Herrmann DN; Logigian EL
    Muscle Nerve; 2006 Jun; 33(6):771-7. PubMed ID: 16523511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simplified electrodiagnostic criteria of diabetic polyneuropathy in field study (KCIS No. 14).
    Hsu WC; Chiu YH; Chen WH; Chiu HC; Liou HH; Chen TH
    Neuroepidemiology; 2007; 28(1):50-5. PubMed ID: 17215587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy.
    Thaisetthawatkul P; Logigian EL; Herrmann DN
    Neurology; 2002 Nov; 59(10):1526-32. PubMed ID: 12451191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological patterns of diabetic polyneuropathy.
    Bagai K; Wilson JR; Khanna M; Song Y; Wang L; Fisher MA
    Electromyogr Clin Neurophysiol; 2008; 48(3-4):139-45. PubMed ID: 18551834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve conduction studies in polyneuropathy: practical physiology and patterns of abnormality.
    Franssen H; van den Bergh PY
    Acta Neurol Belg; 2006 Jun; 106(2):73-81. PubMed ID: 16898257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disorders.
    Bromberg MB; Albers JW
    Muscle Nerve; 1993 Mar; 16(3):262-6. PubMed ID: 8383290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies.
    Isose S; Kuwabara S; Kokubun N; Sato Y; Mori M; Shibuya K; Sekiguchi Y; Nasu S; Fujimaki Y; Noto Y; Sawai S; Kanai K; Hirata K; Misawa S;
    J Peripher Nerv Syst; 2009 Sep; 14(3):151-8. PubMed ID: 19909478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.